Wiki-MPM
About
Search
Browse
People
Funding
Updates
Search
SERPINA10 and F10
Data Source:
HPRD
(in vitro)
SERPINA10
F10
Description
serpin family A member 10
coagulation factor X
Image
GO Annotations
Cellular Component
Extracellular Space
Endoplasmic Reticulum Lumen
Extracellular Exosome
Extracellular Region
Extracellular Space
Endoplasmic Reticulum Lumen
Golgi Lumen
Plasma Membrane
Intrinsic Component Of External Side Of Plasma Membrane
Molecular Function
Serine-type Endopeptidase Inhibitor Activity
Protein Binding
Heparin Binding
Serine-type Endopeptidase Activity
Calcium Ion Binding
Protein Binding
Phospholipid Binding
Biological Process
Blood Coagulation
Negative Regulation Of Endopeptidase Activity
Post-translational Protein Modification
Cellular Protein Metabolic Process
Regulation Of Acrosome Reaction
Proteolysis
Endoplasmic Reticulum To Golgi Vesicle-mediated Transport
Blood Coagulation
Blood Coagulation, Extrinsic Pathway
Positive Regulation Of Cell Migration
Positive Regulation Of Protein Kinase B Signaling
Pathways
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
Post-translational protein phosphorylation
Extrinsic Pathway of Fibrin Clot Formation
Intrinsic Pathway of Fibrin Clot Formation
Common Pathway of Fibrin Clot Formation
Gamma-carboxylation of protein precursors
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
Removal of aminoterminal propeptides from gamma-carboxylated proteins
Defective factor IX causes thrombophilia
Defective cofactor function of FVIIIa variant
Defective F9 variant does not activate FX
Drugs
Antihemophilic factor, human recombinant
Coagulation factor VIIa Recombinant Human
Coagulation Factor IX (Recombinant)
Fondaparinux
Heparin
Enoxaparin
gamma-carboxy-L-glutamic acid
4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE
SSR-126517E
LY-517717
Rivaroxaban
Lanoteplase
Idraparinux
rNAPc2
Apixaban
Otamixaban
Eribaxaban
(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE
THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE
GW-813893
2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE
N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE
N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE
N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE
5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE
5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide
5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide
5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide
N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE
1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE
5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE
5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE
5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE
THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE
3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE
4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE
1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE
Edoxaban
Turoctocog alfa
Protamine sulfate
Bemiparin
Kappadione
Antithrombin Alfa
Betrixaban
Nafamostat
Protein S human
Coagulation factor VII human
Anti-inhibitor coagulant complex
Coagulation Factor IX Human
Antihemophilic factor human
Albutrepenonacog alfa
Emicizumab
Nonacog beta pegol
Lonoctocog alfa
Moroctocog alfa
Turoctocog alfa pegol
Diseases
GWAS
Blood protein levels (
29875488
)
Emphysema imaging phenotypes (
26030696
)
Post bronchodilator FEV1 (
26634245
)
Post bronchodilator FEV1/FVC ratio (
26634245
)
Waist-to-hip ratio adjusted for body mass index (
28270201
)
Bipolar disorder (
31043756
)
Blood protein levels (
30072576
29875488
28240269
)
Factor VII (
17903294
)
High light scatter reticulocyte count (
32888494
)
High light scatter reticulocyte percentage of red cells (
32888494
)
Interacting Genes
3 interacting genes:
F10
PIAS3
PSMB7
21 interacting genes:
APOH
F3
F5
F7
F8
GAD2
GGCX
H1-2
MGST3
NBPF19
NOTCH2NLA
PLAT
PLG
PRKAB1
PROS1
SERPINA10
SERPINA5
SERPINB6
SERPINB8
TFPI
UBQLN2
Entrez ID
51156
2159
HPRD ID
09245
01966
Ensembl ID
ENSG00000140093
ENSG00000126218
Uniprot IDs
A0A024R6I6
G3V2W1
Q9UK55
P00742
Q5JVE7
Q5JVE8
PDB IDs
3F1S
3H5C
4AFX
4AJU
1C5M
1EZQ
1F0R
1F0S
1FAX
1FJS
1FXY
1G2L
1G2M
1HCG
1IOE
1IQE
1IQF
1IQG
1IQH
1IQI
1IQJ
1IQK
1IQL
1IQM
1IQN
1KSN
1LPG
1LPK
1LPZ
1LQD
1MQ5
1MQ6
1MSX
1NFU
1NFW
1NFX
1NFY
1NL8
1P0S
1V3X
1WU1
1XKA
1XKB
1Z6E
2BMG
2BOH
2BOK
2BQ6
2BQ7
2BQW
2CJI
2D1J
2EI6
2EI7
2EI8
2FZZ
2G00
2GD4
2H9E
2J2U
2J34
2J38
2J4I
2J94
2J95
2JKH
2P16
2P3F
2P3T
2P3U
2P93
2P94
2P95
2PHB
2PR3
2Q1J
2RA0
2UWL
2UWO
2UWP
2VH0
2VH6
2VVC
2VVU
2VVV
2VWL
2VWM
2VWN
2VWO
2W26
2W3I
2W3K
2WYG
2WYJ
2XBV
2XBW
2XBX
2XBY
2XC0
2XC4
2XC5
2Y5F
2Y5G
2Y5H
2Y7X
2Y7Z
2Y80
2Y81
2Y82
3CEN
3CS7
3ENS
3FFG
3HPT
3IIT
3K9X
3KL6
3KQB
3KQC
3KQD
3KQE
3LIW
3M36
3M37
3Q3K
3SW2
3TK5
3TK6
4A7I
4BTI
4BTT
4BTU
4Y6D
4Y71
4Y76
4Y79
4Y7A
4Y7B
4ZH8
4ZHA
5JQY
5JTC
5JZ8
5JZU
5K0H
5VOE
5VOF
6Q9F
6Q9I
6RK9
Enriched GO Terms of Interacting Partners
?
Tagcloud
?
Tagcloud (Difference)
?
Tagcloud (Intersection)
?